These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 31778601

  • 21. Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension.
    Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Yamada S, Ueda Y, Koide H.
    Am J Med Sci; 2012 Jan; 343(1):46-51. PubMed ID: 21760473
    [Abstract] [Full Text] [Related]

  • 22. Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure.
    Okubo Y, Sairaku A, Morishima N, Ogi H, Matsumoto T, Kinoshita H, Kihara Y.
    J Card Fail; 2018 Aug; 24(8):520-524. PubMed ID: 30026130
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
    Clin Nephrol; 2006 Jan; 65(1):1-6. PubMed ID: 16429835
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K.
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical significance on serum intestinal fatty acid binding protein and D-lactic acid levels in early intestinal injury of patients with sepsis].
    Zhang X, Liu D, Wang Y, Yan J, Yang X.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):545-550. PubMed ID: 31198137
    [Abstract] [Full Text] [Related]

  • 32. Urinary L-FABP as a marker of vesicoureteral reflux in children: could it also have a protective effect on the kidney?
    Benzer M, Tekin Neijmann S, Gültekin ND, Uluturk Tekin A.
    Int Urol Nephrol; 2017 Jan; 49(1):1-12. PubMed ID: 27550232
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease.
    Reed B, Nobakht E, Dadgar S, Bekheirnia MR, Masoumi A, Belibi F, Yan XD, Cadnapaphornchai M, Schrier RW.
    Am J Kidney Dis; 2010 Jul; 56(1):50-6. PubMed ID: 20452711
    [Abstract] [Full Text] [Related]

  • 35. Predicting acute kidney injury using urinary liver-type fatty-acid binding protein and serum N-terminal pro-B-type natriuretic peptide levels in patients treated at medical cardiac intensive care units.
    Naruse H, Ishii J, Takahashi H, Kitagawa F, Nishimura H, Kawai H, Muramatsu T, Harada M, Yamada A, Motoyama S, Matsui S, Hayashi M, Sarai M, Watanabe E, Izawa H, Ozaki Y.
    Crit Care; 2018 Aug 18; 22(1):197. PubMed ID: 30119691
    [Abstract] [Full Text] [Related]

  • 36. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
    Diabetes Care; 2005 Nov 18; 28(11):2728-32. PubMed ID: 16249547
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR, Grantham JJ.
    Dis Mon; 1995 Nov 18; 41(11):693-765. PubMed ID: 7587886
    [Abstract] [Full Text] [Related]

  • 39. Clinical Scenarios in Chronic Kidney Disease: Cystic Renal Diseases.
    Meola M, Samoni S, Petrucci I.
    Contrib Nephrol; 2016 Nov 18; 188():120-30. PubMed ID: 27169740
    [Abstract] [Full Text] [Related]

  • 40. Urine liver-type fatty acid-binding protein predicts graft outcome up to 2 years after kidney transplantation.
    Yang J, Choi HM, Seo MY, Lee JY, Kim K, Jun H, Jung CW, Park KT, Kim MG, Jo SK, Cho W, Kim HK.
    Transplant Proc; 2014 Nov 18; 46(2):376-80. PubMed ID: 24655967
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.